Access Biotechnology
North America, New York, United States, New York
Description
Access Biotechnology is an investment arm of Access Industries that focuses on private and public biopharma companies.
Investor Profile
Access Biotechnology has made 38 investments, with 8 in the past 12 months and 37% as lead.
Stage Focus
- Series B (32%)
- Post Ipo Equity (29%)
- Series A (29%)
- Series Unknown (5%)
- Seed (3%)
- Series C (3%)
Country Focus
- United States (95%)
- United Kingdom (3%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Denmark (3%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Pharmaceutical
- Medical
- Biopharma
- Life Science
- Bioinformatics
- Biometrics
- Oncology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
